IP Verse

Bluebird Bio competitive analysis

Loading summary...

Latest patents of Bluebird Bio opposed by its competitors

Explore Bluebird Bio's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4151720
Aug 7, 2024Vcn Enhancer Compositions And Methods Of Using The Same1
EP3689899
Nov 24, 2021Mnd Promoter Chimeric Antigen Receptors1
EP2760994
Sep 15, 2021Compounds For Improved Viral Transduction2
EP3134095
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell Therapies3
EP3134432
Dec 25, 2019Mnd Promoter Chimeric Antigen Receptors1
EP3269802
Oct 23, 2019Compounds For Improved Viral Transduction2

Latest publications and patents of Bluebird Bio New

Explore the latest publications and patents granted to Bluebird Bio, showcasing their recent innovations and technological advancements.

Last updated on: Oct 17, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Bluebird Bio

EP4151720
Aug 7, 2024Vcn Enhancer Compositions And Methods Of Using The SameGranted And Under Opposition
EP3689899
Nov 24, 2021Mnd Promoter Chimeric Antigen ReceptorsRevoked
EP2760994
Sep 15, 2021Compounds For Improved Viral TransductionPatent Maintained As Amended
EP3134095
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell TherapiesRevoked
EP3134432
Dec 25, 2019Mnd Promoter Chimeric Antigen ReceptorsRevoked
EP3269802
Oct 23, 2019Compounds For Improved Viral TransductionRevoked

Latest PTAB cases involving Bluebird Bio

Discover the latest PTAB cases involving Bluebird Bio, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 23, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Bluebird Bio

IPR2023-00070Oct 18, 2022BLUEBIRD BIOSLOAN KETTERING INSTITUTE FOR CANCER RESEARCHFinal Written Decision
IPR2023-00074Oct 18, 2022BLUEBIRD BIOSLOAN KETTERING INSTITUTE FOR CANCER RESEARCHFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Bluebird Bio with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BLUEBIRD BIO - 102 -
BOULT WADE TENNANT52 - - -
GLAXOSMITHKLINE29112812
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH - 6 - 3